chondroitin sulfate sulfate | Chondroitin-AKOS ointment 5%, 30 g

Latin name

Chondroitin- AKOS

Release form

ointment for external use

Packaging

In an aluminum tube 30 g of ointment for external use. In the package 1 tube.

Pharmacological action

Ointment Chondroitin-AKOS - stimulator of the regeneration of cartilage tissue in the joints (chondroprotector). Chondroitin sulfate is a high molecular weight mucopolysaccharide, which is obtained from the cartilage of the cattle trachea. It affects the metabolic processes in hyaline and fibrous cartilage, reduces degenerative changes in the cartilage tissue of the joints, stimulates the biosynthesis of glycosaminoglycans in chondrocytes. It suppresses the activity of enzymes that cause damage to cartilage, promotes the regeneration of the articular bag and cartilage surfaces of joints, increases the production of intraarticular fluid. It improves calcium-phosphorus metabolism and reduces the loss of calcium in cartilage, slows down bone resorption, normalizes metabolism in hyaline tissue, and accelerates regeneration processes. Structurally close to heparin, it prevents the formation of fibrin blood clots in the synovial and subchondral microvasculature. As a result of exposure, pain decreases and mobility of affected joints increases.

Dimethyl sulfoxide, which is part of the ointment, has an anti-inflammatory, analgesic and fibrinolytic effect, promotes better penetration of chondroitin sulfate through the cell membranes deep into the tissues.

Chondroitin-AKOS ointment has an analgesic and anti-inflammatory effect, normalizes metabolism and stimulates the recovery processes in the tissues of the joints, leads to a decrease and disappearance of pain in the joints, an increase in joint mobility and to a slowdown in the progression of osteoarthritis and osteochondrosis.

Indications

Treatment and prevention of osteochondrosis, osteoarthrosis of the peripheral joints and spine.

Contraindications

- An acute inflammatory process in the wound area at the site of the ointment.

- Common tissue necrosis.

- Excessive granulation, violation of the integrity of the skin at the site of the alleged application of the ointment.

- Hypersensitivity to the drug.

Use during pregnancy and lactation

The doctor determines the need for the drug during pregnancy and lactation (breastfeeding) individually.

Composition

1 g of ointment for external use contains: chondroitin sulfate 50 mg.

Excipients: dimethyl sulfoxide (100 mg / g), anhydrous lanolin, medical vaseline, purified water.

Dosage and administration

Ointment is applied 2-3 times / day to the skin above the lesion and rubbed for 2-3 minutes until completely absorbed. Usually the course of treatment is from 2-3 weeks to 2 months. If necessary, repeat the treatment.

Side effects of

in rare cases, allergic reactions requiring withdrawal of the drug are possible.

Drug Interaction

No adverse drug interaction was observed when prescribing Chondroitin-AKOS ointment on the background of other drugs included in conventional treatment regimens for degenerative joint and spine diseases.

Storage Conditions

The product should be stored in a dark place at 2 ° to 20 РC.

Shelf life

3 years.

Deystvuyushtee substance

chondroitin sulyfat

Conditions for dispensing from pharmacies

Without a prescription

dosage form

ointment

Possible product names

Chondroitin-AKOS 5% Ointment d / nar. approx. 30g Tube

Chondroitin -AKOS ointment 5% 30g

Chondroitin gel d / outer approx. 5% 30 g

HONDROITIN-AKOS 5% 30.0 OINTMENT

HONDROITIN-AKOS 5% OINTMENT D / NAR. NOTE 30G TUBA

Synthesis AKOMP, Russia